Abstract
Cisplatin, as a first-line chemotherapy drug for advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC), ofte......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
